Addex Therapeutics Ltd (ADXN)
8.15
-0.35 (-4.12%)
At close: Mar 03, 2025, 3:12 PM
8.25
1.23%
After-hours: Mar 03, 2025, 02:54 PM EST
Addex Therapeutics Ltd Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 |
| Net Income | -10.56M | -20.8M | -15.35M | -12.86M | -14.78M | -1.64M | -3.28M | -3.15M | -4.2M | -1.77M | -14.46M | -27.02M | -31.14M | -33.65M | -42.69M | -22.07M | -35.09M | -20.54M |
| Depreciation & Amortization | 305.95K | 323.14K | 347.61K | 378.75K | 333.84K | 2.94K | 15.25K | 25.76K | 25.88K | 110.14K | 662.55K | 2.1M | 2.93M | 2.94M | 2.84M | 2.02M | 1.8M | 2.52M |
| Stock-Based Compensation | 1.79M | 3.68M | 1.18M | 1.18M | 1.69M | 2.3M | 800.19K | 197.35K | 355.91K | 275.74K | 174.47K | 580.48K | n/a | n/a | n/a | n/a | 599.67K | 526.78K |
| Other Working Capital | -92.76K | 409.77K | -665.15K | -1.82M | 2.66M | 742.72K | 560.44K | 194.28K | -5.75K | -107.25K | 758.94K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Non-Cash Items | 249.64K | 204.13K | 32.93K | 972.63K | 523.88K | 331.93K | 45.35K | 19.79K | 336.27K | -21.78K | 3.23K | 8.41K | 1.42M | 1.75M | 815.64K | -1.46M | -2.57M | -361.95K |
| Deferred Income Tax | n/a | n/a | -150.59K | -27.72K | 96.53K | 20.01K | 19.52K | 17.82K | 863.46K | -281.63K | -616.99K | 97.59K | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 213.76K | 157.68K | -761.57K | -1.82M | 2.66M | 742.72K | 265.15K | 194.28K | -5.75K | -107.25K | -1.54M | -5.23M | 246.77K | -2.38M | -335.54K | 3.71M | 2.25M | -1.7M |
| Operating Cash Flow | -7.99M | -16.44M | -14.71M | -12.18M | -9.48M | 1.75M | -2.13M | -2.69M | -2.63M | -1.8M | -15.78M | -29.45M | -26.55M | -31.34M | -39.38M | -17.79M | -33M | -19.56M |
| Capital Expenditures | -6.84K | -581 | -31.55K | -59.41K | -28.46K | -9.05K | -697 | -11.22K | n/a | n/a | n/a | -330.91K | -204.31K | -453.02K | -4.21M | -5.61M | -2.73M | -357.41K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.68K | 360.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -14.79K | -52.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 3.55K | 1.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 3.55K | 1.24K | n/a | -14.79K | -5.37K | n/a | 9.71K | 399.9K | 373.45K | 256.07K | 105.87K | -553.96K | -519.78K | 315.13K | 3.44M | 2.54M | -543.04K |
| Investing Cash Flow | -6.84K | 2.97K | -30.31K | -59.41K | -43.25K | -61.74K | -697 | -1.51K | 399.9K | 373.45K | 256.07K | -225.04K | -758.27K | -972.8K | -3.9M | -2.17M | -193.49K | -900.45K |
| Debt Repayment | -281.79K | -288.08K | -309.62K | -367.41K | -316.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.05K | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -5.37K | n/a | n/a | n/a | n/a | n/a | n/a | -117 | -148.78K | n/a | -32.15K | -63.07K | -7.22K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 3.2M | 1.71M | 2.75M | -306.2K | -152.89K | -3.1M | -25.74K | -32.32K | -253.7K | 4.32K | -167.1K | -780.2K | -183.14K | 13.81M | -3.12K | -64.09K | -4.5M | -611.77K |
| Financial Cash Flow | 5.26M | 3.1M | 16.4M | 46.4K | -463.69K | 37.39M | 3.36M | 1.49M | 2.93M | 472.65K | 3.18M | 8.9M | -183.25K | 19.71M | 315.16K | -102.29K | 132.31M | 39.61M |
| Net Cash Flow | -3.09M | -13.53M | 1.79M | -12.84M | -10.13M | 39.09M | 1.17M | -1.22M | 653.99K | -933.79K | -12.34M | -20.81M | -27.73M | -12.76M | -42.91M | -20.57M | 99.1M | 19.28M |
| Free Cash Flow | -8M | -16.44M | -14.74M | -12.24M | -9.51M | 1.74M | -2.14M | -2.71M | -2.63M | -1.8M | -15.78M | -29.78M | -26.75M | -31.79M | -43.59M | -23.4M | -35.73M | -19.92M |